Results 321 to 330 of about 1,520,463 (346)

Issues with implementing a high‐quality lung cancer screening program

Ca-A Cancer Journal for Clinicians, 2014
James L Mulshine
exaly  

Biomarker enrichment strategies: matching trial design to biomarker credentials

Nature Reviews Clinical Oncology, 2013
Boris Freidlin
exaly  

MAIA under the microscope — bringing trial design into focus

Nature Reviews Clinical Oncology, 2019
Prashant Kapoor, S Vincent Rajkumar
exaly  

Cluster Randomized Controlled Trial

2023
openaire   +1 more source

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Lancet, The, 2016
Ian J Jacobs, Usha Menon, Andy Ryan
exaly  

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Lancet, The, 2012
Peter Sandercock, Joanna M Wardlaw, Richard I Lindley   +2 more
exaly  

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Lancet, The, 2008
Homer Yang, Gordon Guyatt, Kate Leslie
exaly  

Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial

Lancet, The, 2016
Rajesh Patel, Janet T Powell
exaly  

Cancer therapy and the randomized clinical trial: good medicine?

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Cluster Randomization Trial

2014
openaire   +1 more source